Close

CHMP Issues Positive Opinion on AbbVie's (ABBV) HUMIRA as non-Infectious Uveitis Treatment

May 27, 2016 7:09 AM EDT Send to a Friend
AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login